High Court Told Tyvaso Row Petition Based On 'False' Premise <https://www.law360.com/delaware/articles/1874100?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-08-29&read_main=1&nlsidx=0&nlaidx=6> By Andrew Karpan A small pharmaceutical startup behind a drug that would compete with the blockbuster high blood pressure treatment Tyvaso says United Therapeutics is making a "fundamentally false" argument to the U.S. Supreme Court about why an appeals court rejected United Therapeutics' case. 2 documents attached | Read full article » <https://www.law360.com/delaware/articles/1874100?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-08-29&read_more=1&nlsidx=0&nlaidx=6> | Save to favorites » <https://www.law360.com/delaware/articles/1874100?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-08-29&read_later=1&nlsidx=0&nlaidx=6>